513 related articles for article (PubMed ID: 17891158)
1. PPARalpha agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages.
Paukkeri EL; Leppänen T; Sareila O; Vuolteenaho K; Kankaanranta H; Moilanen E
Br J Pharmacol; 2007 Dec; 152(7):1081-91. PubMed ID: 17891158
[TBL] [Abstract][Full Text] [Related]
2. Orazipone inhibits activation of inflammatory transcription factors nuclear factor-kappa B and signal transducer and activator of transcription 1 and decreases inducible nitric-oxide synthase expression and nitric oxide production in response to inflammatory stimuli.
Sareila O; Hämäläinen M; Nissinen E; Kankaanranta H; Moilanen E
J Pharmacol Exp Ther; 2008 Feb; 324(2):858-66. PubMed ID: 18039960
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of classical PKC isoenzymes downregulates STAT1 activation and iNOS expression in LPS-treated murine J774 macrophages.
Salonen T; Sareila O; Jalonen U; Kankaanranta H; Tuominen R; Moilanen E
Br J Pharmacol; 2006 Apr; 147(7):790-9. PubMed ID: 16432499
[TBL] [Abstract][Full Text] [Related]
4. Requirement for endogenous heat shock factor 1 in inducible nitric oxide synthase induction in murine microglia.
Huang C; Lu X; Tong L; Wang J; Zhang W; Jiang B; Yang R
J Neuroinflammation; 2015 Oct; 12():189. PubMed ID: 26467650
[TBL] [Abstract][Full Text] [Related]
5. Withaferin A inhibits iNOS expression and nitric oxide production by Akt inactivation and down-regulating LPS-induced activity of NF-kappaB in RAW 264.7 cells.
Oh JH; Lee TJ; Park JW; Kwon TK
Eur J Pharmacol; 2008 Dec; 599(1-3):11-7. PubMed ID: 18838070
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages.
Zhou R; Zheng SX; Tang W; He PL; Li XY; Yang YF; Li YC; Geng JG; Zuo JP
J Pharmacol Exp Ther; 2006 Jan; 316(1):121-8. PubMed ID: 16166270
[TBL] [Abstract][Full Text] [Related]
7. Suppressive effect of novel aromatic diamine compound on nuclear factor-kappaB-dependent expression of inducible nitric oxide synthase in macrophages.
Shin HM; Byung Hak Kim ; Eun Yong Chung ; Jung SH; Yeong Shik Kim ; Kyung Rak Min ; Kim Y
Eur J Pharmacol; 2005 Oct; 521(1-3):1-8. PubMed ID: 16183054
[TBL] [Abstract][Full Text] [Related]
8. Isoliquiritigenin isolated from the roots of Glycyrrhiza uralensis inhibits LPS-induced iNOS and COX-2 expression via the attenuation of NF-kappaB in RAW 264.7 macrophages.
Kim JY; Park SJ; Yun KJ; Cho YW; Park HJ; Lee KT
Eur J Pharmacol; 2008 Apr; 584(1):175-84. PubMed ID: 18295200
[TBL] [Abstract][Full Text] [Related]
9. Ergolide, sesquiterpene lactone from Inula britannica, inhibits inducible nitric oxide synthase and cyclo-oxygenase-2 expression in RAW 264.7 macrophages through the inactivation of NF-kappaB.
Whan Han J; Gon Lee B; Kee Kim Y; Woo Yoon J; Kyoung Jin H; Hong S; Young Lee H; Ro Lee K; Woo Lee H
Br J Pharmacol; 2001 Jun; 133(4):503-12. PubMed ID: 11399667
[TBL] [Abstract][Full Text] [Related]
10. Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kappaB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide.
Oh GS; Pae HO; Lee BS; Kim BN; Kim JM; Kim HR; Jeon SB; Jeon WK; Chae HJ; Chung HT
Free Radic Biol Med; 2006 Jul; 41(1):106-19. PubMed ID: 16781459
[TBL] [Abstract][Full Text] [Related]
11. Calcineurin inhibitors down-regulate iNOS expression by destabilizing mRNA.
Hämäläinen M; Korhonen R; Moilanen E
Int Immunopharmacol; 2009 Feb; 9(2):159-67. PubMed ID: 18692599
[TBL] [Abstract][Full Text] [Related]
12. Effects of luteolin on the release of nitric oxide and interleukin-6 by macrophages stimulated with lipopolysaccharide from Prevotella intermedia.
Choi EY; Jin JY; Choi JI; Choi IS; Kim SJ
J Periodontol; 2011 Oct; 82(10):1509-17. PubMed ID: 21309717
[TBL] [Abstract][Full Text] [Related]
13. Suppression of nitric oxide induction and pro-inflammatory cytokines by novel proteasome inhibitors in various experimental models.
Qureshi AA; Tan X; Reis JC; Badr MZ; Papasian CJ; Morrison DC; Qureshi N
Lipids Health Dis; 2011 Oct; 10():177. PubMed ID: 21992595
[TBL] [Abstract][Full Text] [Related]
14. PPAR agonists amplify iNOS expression while inhibiting NF-kappaB: implications for mesangial cell activation by cytokines.
Cernuda-Morollón E; Rodríguez-Pascual F; Klatt P; Lamas S; Pérez-Sala D
J Am Soc Nephrol; 2002 Sep; 13(9):2223-31. PubMed ID: 12191966
[TBL] [Abstract][Full Text] [Related]
15. Acetaminophen inhibits iNOS gene expression in RAW 264.7 macrophages: differential regulation of NF-kappaB by acetaminophen and salicylates.
Ryu YS; Lee JH; Seok JH; Hong JH; Lee YS; Lim JH; Kim YM; Hur GM
Biochem Biophys Res Commun; 2000 Jun; 272(3):758-64. PubMed ID: 10860828
[TBL] [Abstract][Full Text] [Related]
16. 8-Hydroxyquinoline inhibits iNOS expression and nitric oxide production by down-regulating LPS-induced activity of NF-kappaB and C/EBPbeta in Raw 264.7 cells.
Kim YH; Woo KJ; Lim JH; Kim S; Lee TJ; Jung EM; Lee JM; Park JW; Kwon TK
Biochem Biophys Res Commun; 2005 Apr; 329(2):591-7. PubMed ID: 15737626
[TBL] [Abstract][Full Text] [Related]
17. Dioscoreanone suppresses LPS-induced nitric oxide production and inflammatory cytokine expression in RAW 264.7 macrophages by NF-κB and ERK1/2 signaling transduction.
Itharat A; Hiransai P
J Cell Biochem; 2012 Nov; 113(11):3427-35. PubMed ID: 22678775
[TBL] [Abstract][Full Text] [Related]
18. The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN.
Lee HJ; Oh YK; Rhee M; Lim JY; Hwang JY; Park YS; Kwon Y; Choi KH; Jo I; Park SI; Gao B; Kim WH
J Mol Biol; 2007 Jun; 369(4):967-84. PubMed ID: 17475277
[TBL] [Abstract][Full Text] [Related]
19. Anethum graveloens flower extracts inhibited a lipopolysaccharide-induced inflammatory response by blocking iNOS expression and NF-κB activity in macrophages.
Kim YJ; Shin Y; Lee KH; Kim TJ
Biosci Biotechnol Biochem; 2012; 76(6):1122-7. PubMed ID: 22790933
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
